News

The latest hurdle that was jumped for the implantable device was the successful implantation in sheep.

Researchers at the University of Toronto have developed a new technique of injecting healthy cells into eyes affected by vision loss due to age-related macular degeneration (AMD) or retinitis pigme...

A recent study was published in the journal Science Advances which sheds light on how a build-up of damaging DNA in the eyes of people with macular degeneration can lead to blindness.

Currently, there are no FDA-approved treatments available to treat dry AMD. Lineage Cell Therapeutics is currently conducting a clinical trial on its newest cell transplant product developed to tre...

Researchers from the Queen Mary University of London have found that age-related macular degeneration is potentially caused by the failure of at least one of five proteins to regulate the immune s...

A research team at the University of Utah found that low levels of a protein known as HTRA1 could be a trigger for the development of age-related macular degeneration (AMD) in specific individuals.

EyePoint Pharmaceuticals recently announced results of the Phase 1 clinical trial of their new wet age-related macular degeneration treatment, EYP-1901.

The new device offers a continuous therapeutic dose of ranibizumab to the eye in place of regular eye injections.

With so many consumers looking towards macular degeneration supplements to help stop the progression of the vision-robbing disease, it's important that they know that what they are reading on the l...